Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_assertion type Assertion NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_head.
- NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_assertion description "[Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_provenance.
- NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_assertion evidence source_evidence_literature NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_provenance.
- NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_assertion SIO_000772 23208952 NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_provenance.
- NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_assertion wasDerivedFrom befree-2016 NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_provenance.
- NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_assertion wasGeneratedBy ECO_0000203 NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_provenance.